Medical AIHOMA-IR is a simple fasting surrogate for insulin resistance derived by Matthews and colleagues in 1985. A healthy reference individual scores about 1; higher values suggest more insulin resistance. There is no single universal threshold: cutoffs vary with the insulin assay, population, age, and BMI, so the number is best read against your own laboratory's reference range and trended over time.
| Band | Meaning |
|---|---|
| Around 1 or below (reference range) | Consistent with normal fasting insulin sensitivity in many populations (a healthy reference individual scores about 1). Interpret against your own laboratory's reference range. |
| Intermediate (interpret with caution) | An intermediate zone. Some studies treat values from about 2.0 to 2.5 as a threshold for insulin resistance, but this is assay- and population-dependent and not universally agreed. Read alongside BMI, waist, lipids, and glucose. |
| Suggestive of insulin resistance (population-dependent) | A value around or above 2.5 is the most commonly cited general-population cutoff suggesting insulin resistance, though thresholds are lower in some Asian cohorts (about 1.4 to 2.0) and vary by assay. Treat as a prompt for metabolic assessment, not a diagnosis. |
HOMA-IR (SI) = fasting insulin (mU/L) x fasting glucose (mmol/L) / 22.5. Equivalently, with glucose in mg/dL: HOMA-IR = fasting insulin (uU/mL) x fasting glucose (mg/dL) / 405. (405 = 22.5 x 18, since glucose mmol/L = mg/dL / 18.)HOMA was described by Matthews et al. (1985). The simple HOMA-IR approximation is reproduced here for education and is not affiliated with the original authors. The updated computer model HOMA2 gives slightly different values.
A healthy reference individual scores about 1. Many general-population studies treat values around or above 2.0 to 2.5 as suggesting insulin resistance, but there is no universal cutoff: it depends on the insulin assay, the population (lower in some Asian cohorts), age, sex, and BMI. Use your own laboratory's reference range.
Insulin assays are not standardised and can differ by roughly a quarter between laboratories, and the glucose unit (mg/dL vs mmol/L) must match the formula. The same blood sample can therefore produce different HOMA-IR numbers in different settings, so trends within one lab are more meaningful than cross-lab comparisons.
No. It is a fasting surrogate for research and screening. Diagnosis relies on glucose and HbA1c criteria and the broader clinical picture (weight, waist, lipids, blood pressure). HOMA-IR is also invalid when beta-cell function is abnormal or insulin is being given.
Calculators give a number. When the patient in front of you needs the reasoning behind it, with the sources, the product is what does the looking-up.
Medical AI returns evidence-grounded answers backed by real citations. It is a reference tool, and these terms describe how it should and should not be used.
Medical AI is an information and reference tool intended for educational use only. The answers it returns are not medical advice, diagnosis, or treatment. Always consult a qualified doctor or healthcare professional with any question concerning a medical condition.
Medical AI is designed for use by practicing clinicians. It is not intended for direct patient use and is not a substitute for professional clinical judgment. Apply your own training and current guidelines to every decision an answer informs.
We do not collect, store, or process personally identifiable patient information (PHI or PII). Do not enter names, dates of birth, medical record numbers, or any other patient identifiers into the composer.
Medical knowledge evolves rapidly. Citations carry their publication date, so consult the primary source and the most recent clinical guideline before acting on anything material.